A new class of drugs may help in the treatment of acute myeloid leukaemia (AML), according to a joint UK-US project.
Researchers at Ludwig Institute for Cancer Research in Oxford, UK, have pinpointed GSK3 inhibitors as a potential combination ther...
2 months ago
British researchers have announced plans to develop new tests for monitoring patients with monoclonal gammopathy of unknown significance (MGUS).
Researchers at the University of Birmingham hope to make monitoring “more efficient and convenient”.
T...
2 months ago
